newsfilter
← Latest News
GlobeNewswire·

Odyssey Therapeutics to Participate in Stifel 2026 Virtual Immunology and Inflammation Forum

BOSTON, Sept. 16, 2026 (GLOBE NEWSWIRE) -- Odyssey Therapeutics, Inc. (NASDAQ:ODTX) ("Odyssey" or the "Company"), a clinical-stage biopharmaceutical company seeking to transform the standard of care